SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Net Income for Purposes of Determining Basic and Diluted EPS |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 30, | | June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Net loss attributed to Douglas Elliman Inc. | $ | (2,734) | | | $ | (22,673) | | | $ | (19,010) | | | $ | (28,658) | | | Income attributable to participating securities | — | | | — | | | — | | | — | | | Net loss available to common stockholders attributed to Douglas Elliman Inc. | $ | (2,734) | | | $ | (22,673) | | | $ | (19,010) | | | $ | (28,658) | |
|
| Schedule of Basic and Diluted EPS Calculation Shares |
Basic and diluted EPS were calculated using the following shares of common stock for the periods presented below: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 30, | | June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Weighted-average shares for basic and diluted EPS | 85,714,520 | | | 84,464,283 | | | 85,674,347 | | | 84,417,308 | | | | | | | | | | | | | | | | | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following was outstanding during the three and six months ended June 30, 2025, but was not included in the computation of diluted EPS because the effect was anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 30, | | June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Weighted-average number of shares issuable upon conversion of debt | — | | | 33,333,333 | | | — | | | 33,333,333 | | | Weighted-average conversion price | $ | — | | | $ | 1.50 | | | $ | — | | | $ | 1.50 | |
|
| Schedule of Components of Cash, Cash Equivalents and Restricted Cash |
The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows: | | | | | | | | | | | | | | | June 30,
2026 | | December 31,
2025 | | | | Cash and cash equivalents | $ | 105,225 | | | $ | 115,510 | | | | | Restricted cash and cash equivalents in current assets | 5,995 | | | 4,716 | | | | | Restricted cash and cash equivalents included in other assets | 2,649 | | | 2,483 | | | | Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows | $ | 113,869 | | | $ | 122,709 | | | |
|
| Schedule of Investment And Other Losses |
Investment and other losses consist of the following: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 30, | | June 30, | | 2026 | | 2025 | | 2026 | | 2025 | Net unrealized losses on PropTech convertible trading debt securities | $ | — | | | $ | (44) | | | $ | — | | | $ | (44) | | Net unrealized losses on long-term investments at fair value | (17) | | | (15) | | | (53) | | | (136) | | | Net (losses) gains on long-term investment securities without a readily determinable fair value that does not qualify for the NAV practical expedient | — | | | — | | | (4) | | | 78 | | | Other income | — | | | 22 | | | — | | | 43 | | | | | | | | | | Investment and other losses | $ | (17) | | | $ | (37) | | | $ | (57) | | | $ | (59) | |
|